CA Stock MarketDetailed Quotes

EPRX Eupraxia Pharmaceuticals Inc

Watchlist
  • 4.910
  • +0.180+3.81%
15min DelayMarket Closed Nov 22 16:00 ET
174.91MMarket Cap-3903P/E (TTM)

Eupraxia Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-73.40%-10.19M
-80.53%-7.71M
-34.01%-6.12M
-43.68%-20.68M
-31.70%-5.97M
-48.46%-5.88M
-52.89%-4.27M
-46.79%-4.57M
-25.36%-14.4M
-62.42%-4.53M
Net income from continuing operations
-22.37%-5.99M
36.21%-6.06M
-55.63%-6.16M
-52.53%-28.97M
-25.67%-10.61M
-77.48%-4.9M
-98.88%-9.51M
-31.37%-3.96M
-3.61%-18.99M
-184.32%-8.44M
Operating gains losses
957.84%9.95K
190.79%58.15K
844.56%144.91K
72.44%-59.76K
-274.22%-59.14K
99.46%-1.16K
122.32%20K
-136.25%-19.46K
-122.96%-216.83K
8.15%33.94K
Depreciation and amortization
-2.47%37.76K
10.25%42.03K
-0.10%37.42K
5.16%155.53K
-12.04%41.23K
19.06%38.72K
3.12%38.12K
18.79%37.46K
69.08%147.89K
44.22%46.88K
Unrealized gains and losses of investment securities
--0
-111.79%-430.5K
-345.17%-770.04K
-20.79%836.6K
-210.61%-1.25M
---1.88M
--3.65M
--314.08K
--1.06M
--1.13M
Remuneration paid in stock
41.34%507.25K
246.13%1.47M
-32.86%213.13K
-1.50%1.41M
-57.74%309.84K
342.94%358.88K
115.21%426.12K
-24.71%317.42K
-56.62%1.43M
70.85%733.19K
Other non cashItems
-117.28%-14.23K
-59.15%51.7K
1.68%160.94K
-11.20%586K
-28.73%218.84K
396.20%82.33K
-28.94%126.56K
-21.87%158.29K
-75.32%659.95K
49.77%307.07K
Change In working capital
-1,446.57%-4.74M
-392.93%-2.84M
117.63%250.12K
253.35%5.35M
228.71%5.45M
135.35%351.93K
-41.58%971.06K
-75.31%-1.42M
1,013.35%1.51M
419.20%1.66M
-Change in receivables
382.61%50.43K
-62.70%13.67K
919.02%17.2K
-145.00%-103.71K
-161.53%-124.21K
-41.53%-17.85K
-22.29%36.65K
128.34%1.69K
53.95%230.48K
178.68%201.88K
-Change in prepaid assets
-198.29%-69.46K
-270.84%-884.76K
143.49%125.2K
-206.40%-122.44K
-113.35%-5.95K
-40.50%70.67K
-17.27%-238.58K
31,838.22%51.42K
-178.18%-39.96K
-74.85%44.54K
-Change in payables and accrued expense
-1,678.03%-4.72M
-268.24%-1.97M
107.32%107.71K
321.28%5.58M
295.35%5.58M
127.15%299.11K
-35.50%1.17M
-83.18%-1.47M
461.12%1.32M
420.86%1.41M
Cash from discontinued investing activities
Operating cash flow
-71.41%-10.19M
-80.53%-7.71M
-34.01%-6.12M
-43.68%-20.68M
-30.19%-5.9M
-50.18%-5.94M
-52.89%-4.27M
-46.79%-4.57M
-25.36%-14.4M
-62.42%-4.53M
Investing cash flow
Cash flow from continuing investing activities
-340.27%-42.28K
379.37%17.66K
15.85%-6.79K
-100.75%-73.38K
-100.30%-49.39K
-102.57%-9.6K
99.91%-6.32K
-48.63%-8.07K
186.78%9.83M
334.36%16.57M
Net PPE purchase and sale
-340.27%-42.28K
379.37%17.66K
15.85%-6.79K
68.82%-73.38K
31.75%-49.39K
67.34%-9.6K
95.07%-6.32K
-48.63%-8.07K
30.50%-235.31K
-405.82%-72.36K
Net investment purchase and sale
----
----
----
--0
----
----
----
----
242.66%10.07M
335.80%16.64M
Cash from discontinued investing activities
Investing cash flow
-340.27%-42.28K
379.37%17.66K
15.85%-6.79K
-100.75%-73.38K
-100.30%-49.39K
-102.57%-9.6K
99.91%-6.32K
-48.63%-8.07K
186.78%9.83M
334.36%16.57M
Financing cash flow
Cash flow from continuing financing activities
-128.25%-4.6M
-198.01%-4.5M
11,797.52%23.15M
94.55%21.01M
-105.01%-59.04K
2,698.96%16.29M
-55.37%4.59M
638.09%194.61K
-72.41%10.8M
1,271.48%1.18M
Net issuance payments of debt
-22,915.61%-4.6M
-127,324.75%-4.5M
-3.36%-36.82K
-1.52%-144.44K
-103.73%-85.29K
33.71%-19.99K
89.64%-3.53K
1.51%-35.62K
-101.50%-142.27K
46.42%-41.87K
Net common stock issuance
--0
--0
--22.85M
49.36%15.89M
--0
2,763.14%15.89M
--0
--0
-64.15%10.64M
4,173.22%912.94K
Proceeds from stock option exercised by employees
--0
--0
46.46%337.2K
1,618.51%5.27M
-91.44%26.25K
--421K
--4.59M
--230.23K
--306.77K
--306.77K
Cash from discontinued financing activities
Financing cash flow
-128.25%-4.6M
-198.01%-4.5M
11,797.52%23.15M
94.55%21.01M
-105.01%-59.04K
2,698.96%16.29M
-55.37%4.59M
638.09%194.61K
-72.41%10.8M
1,271.48%1.18M
Net cash flow
Beginning cash position
61.66%23.32M
157.81%35.91M
5.90%19.34M
45.75%18.26M
184.60%24.56M
6.85%14.42M
3.01%13.93M
9.14%18.26M
10,542.18%12.53M
-67.30%8.63M
Current changes in cash
-243.55%-14.83M
-4,001.35%-12.19M
488.67%17.03M
-95.88%256.97K
-145.45%-6.01M
345.39%10.33M
-19.04%312.55K
-38.94%-4.38M
-61.79%6.24M
232.69%13.22M
Effect of exchange rate changes
192.83%178.86K
-317.86%-397.62K
-1,122.24%-460.76K
261.89%821.4K
193.67%786.49K
-168.51%-192.68K
64.46%182.51K
175.10%45.07K
-692.55%-507.4K
-1,689.49%-839.6K
End cash Position
-64.74%8.66M
61.66%23.32M
157.81%35.91M
5.90%19.34M
5.90%19.34M
184.60%24.56M
6.85%14.42M
3.01%13.93M
11.46%18.26M
11.46%18.26M
Free cash from
-71.84%-10.23M
-80.51%-7.72M
-33.92%-6.13M
-41.87%-20.76M
-29.22%-5.95M
-49.32%-5.95M
-46.39%-4.28M
-46.80%-4.58M
-23.76%-14.63M
-64.18%-4.6M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -73.40%-10.19M-80.53%-7.71M-34.01%-6.12M-43.68%-20.68M-31.70%-5.97M-48.46%-5.88M-52.89%-4.27M-46.79%-4.57M-25.36%-14.4M-62.42%-4.53M
Net income from continuing operations -22.37%-5.99M36.21%-6.06M-55.63%-6.16M-52.53%-28.97M-25.67%-10.61M-77.48%-4.9M-98.88%-9.51M-31.37%-3.96M-3.61%-18.99M-184.32%-8.44M
Operating gains losses 957.84%9.95K190.79%58.15K844.56%144.91K72.44%-59.76K-274.22%-59.14K99.46%-1.16K122.32%20K-136.25%-19.46K-122.96%-216.83K8.15%33.94K
Depreciation and amortization -2.47%37.76K10.25%42.03K-0.10%37.42K5.16%155.53K-12.04%41.23K19.06%38.72K3.12%38.12K18.79%37.46K69.08%147.89K44.22%46.88K
Unrealized gains and losses of investment securities --0-111.79%-430.5K-345.17%-770.04K-20.79%836.6K-210.61%-1.25M---1.88M--3.65M--314.08K--1.06M--1.13M
Remuneration paid in stock 41.34%507.25K246.13%1.47M-32.86%213.13K-1.50%1.41M-57.74%309.84K342.94%358.88K115.21%426.12K-24.71%317.42K-56.62%1.43M70.85%733.19K
Other non cashItems -117.28%-14.23K-59.15%51.7K1.68%160.94K-11.20%586K-28.73%218.84K396.20%82.33K-28.94%126.56K-21.87%158.29K-75.32%659.95K49.77%307.07K
Change In working capital -1,446.57%-4.74M-392.93%-2.84M117.63%250.12K253.35%5.35M228.71%5.45M135.35%351.93K-41.58%971.06K-75.31%-1.42M1,013.35%1.51M419.20%1.66M
-Change in receivables 382.61%50.43K-62.70%13.67K919.02%17.2K-145.00%-103.71K-161.53%-124.21K-41.53%-17.85K-22.29%36.65K128.34%1.69K53.95%230.48K178.68%201.88K
-Change in prepaid assets -198.29%-69.46K-270.84%-884.76K143.49%125.2K-206.40%-122.44K-113.35%-5.95K-40.50%70.67K-17.27%-238.58K31,838.22%51.42K-178.18%-39.96K-74.85%44.54K
-Change in payables and accrued expense -1,678.03%-4.72M-268.24%-1.97M107.32%107.71K321.28%5.58M295.35%5.58M127.15%299.11K-35.50%1.17M-83.18%-1.47M461.12%1.32M420.86%1.41M
Cash from discontinued investing activities
Operating cash flow -71.41%-10.19M-80.53%-7.71M-34.01%-6.12M-43.68%-20.68M-30.19%-5.9M-50.18%-5.94M-52.89%-4.27M-46.79%-4.57M-25.36%-14.4M-62.42%-4.53M
Investing cash flow
Cash flow from continuing investing activities -340.27%-42.28K379.37%17.66K15.85%-6.79K-100.75%-73.38K-100.30%-49.39K-102.57%-9.6K99.91%-6.32K-48.63%-8.07K186.78%9.83M334.36%16.57M
Net PPE purchase and sale -340.27%-42.28K379.37%17.66K15.85%-6.79K68.82%-73.38K31.75%-49.39K67.34%-9.6K95.07%-6.32K-48.63%-8.07K30.50%-235.31K-405.82%-72.36K
Net investment purchase and sale --------------0----------------242.66%10.07M335.80%16.64M
Cash from discontinued investing activities
Investing cash flow -340.27%-42.28K379.37%17.66K15.85%-6.79K-100.75%-73.38K-100.30%-49.39K-102.57%-9.6K99.91%-6.32K-48.63%-8.07K186.78%9.83M334.36%16.57M
Financing cash flow
Cash flow from continuing financing activities -128.25%-4.6M-198.01%-4.5M11,797.52%23.15M94.55%21.01M-105.01%-59.04K2,698.96%16.29M-55.37%4.59M638.09%194.61K-72.41%10.8M1,271.48%1.18M
Net issuance payments of debt -22,915.61%-4.6M-127,324.75%-4.5M-3.36%-36.82K-1.52%-144.44K-103.73%-85.29K33.71%-19.99K89.64%-3.53K1.51%-35.62K-101.50%-142.27K46.42%-41.87K
Net common stock issuance --0--0--22.85M49.36%15.89M--02,763.14%15.89M--0--0-64.15%10.64M4,173.22%912.94K
Proceeds from stock option exercised by employees --0--046.46%337.2K1,618.51%5.27M-91.44%26.25K--421K--4.59M--230.23K--306.77K--306.77K
Cash from discontinued financing activities
Financing cash flow -128.25%-4.6M-198.01%-4.5M11,797.52%23.15M94.55%21.01M-105.01%-59.04K2,698.96%16.29M-55.37%4.59M638.09%194.61K-72.41%10.8M1,271.48%1.18M
Net cash flow
Beginning cash position 61.66%23.32M157.81%35.91M5.90%19.34M45.75%18.26M184.60%24.56M6.85%14.42M3.01%13.93M9.14%18.26M10,542.18%12.53M-67.30%8.63M
Current changes in cash -243.55%-14.83M-4,001.35%-12.19M488.67%17.03M-95.88%256.97K-145.45%-6.01M345.39%10.33M-19.04%312.55K-38.94%-4.38M-61.79%6.24M232.69%13.22M
Effect of exchange rate changes 192.83%178.86K-317.86%-397.62K-1,122.24%-460.76K261.89%821.4K193.67%786.49K-168.51%-192.68K64.46%182.51K175.10%45.07K-692.55%-507.4K-1,689.49%-839.6K
End cash Position -64.74%8.66M61.66%23.32M157.81%35.91M5.90%19.34M5.90%19.34M184.60%24.56M6.85%14.42M3.01%13.93M11.46%18.26M11.46%18.26M
Free cash from -71.84%-10.23M-80.51%-7.72M-33.92%-6.13M-41.87%-20.76M-29.22%-5.95M-49.32%-5.95M-46.39%-4.28M-46.80%-4.58M-23.76%-14.63M-64.18%-4.6M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data